ArticleBMC neurology2026
Persistent cognitive dysfunction in patients with migraine: a case series.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCognitive symptoms, including impaired concentration, slowed thinking, and forgetfulness, are common in patients with migraine. Although these symptoms are most prominent during the headache and postdrome phases, some patients experience persistent cognitive symptoms that extend beyond individual migraine attacks and interictal periods. Cortical spreading depression, a key pathophysiological mechanism of migraine, may contribute to neurological and cognitive manifestations and can be visualized indirectly using arterial spin-labeled magnetic resonance imaging (ASL-MRI). We investigated the clinical characteristics of persistent cognitive symptoms in patients with migraine, evaluated cerebral perfusion using ASL-MRI, and assessed the effects of migraine-preventive therapy. CASE PRESENTATION: We present a cohort of 12 consecutive patients with migraine who exhibited cognitive symptoms for over one month, without identifiable physical, neurological, cognitive, or psychiatric disorders. These patients underwent ASL-MRI while experiencing cognitive symptoms. Their ages ranged from 15 to 37 years, comprising five men and seven women. Eleven patients reported cognitive symptoms as their primary complaint during their initial visit, with only three presenting with concomitant headaches on that day. The cognitive symptoms persisted beyond migraine attacks and/or interictal phases, with durations ranging from two months to eight years. All patients displayed regional hypoperfusion in the right or left cerebral hemisphere on ASL-MRI. Treatment with migraine-preventive medications led to improvements in cognitive symptoms. The consistent presence of regional hypoperfusion and the favorable response to migraine-directed therapy suggest that migraine-related cerebral hypoperfusion may contribute to persistent cognitive dysfunction.
conclusionsCognitive symptoms associated with migraine may persist for months to years, even in the absence of ongoing headache attacks. Regional cerebral hypoperfusion may reflect these persistent symptoms, and ASL-MRI may be a useful tool for detecting this abnormality. Migraine should be considered in the differential diagnosis of patients presenting with unexplained, persistent cognitive symptoms, particularly when a history of migraine exists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.